Purchase this article with an account.
Francesca Lazzara, Federica Conti, Mariantonia Ferrara, Myrta Lippera, Michele Coppola, Settimio Rossi, Filippo Drago, Claudio Bucolo, Mario R. Romano; Safety Profile of Lutein- Versus Triamcinolone Acetonide–Based Vitreous Staining. Trans. Vis. Sci. Tech. 2023;12(1):5. https://doi.org/10.1167/tvst.12.1.5.
Download citation file:
© ARVO (1962-2015); The Authors (2016-present)
To assess the safety profile of a new lutein-based vitreous dye (LB-VD) formulation compared with various triamcinolone acetonide (TA) formulations with and without subsequent exposure to perfluorodecalin (PFD) in vitro.
Human adult retinal pigment epithelial cells (ARPE-19) were treated with the following formulations: undiluted preserved TA (TA-BA), diluted preserved TA (D-TA-BA), preservative-free TA (TA-PF), and LB-VD. First, cell tolerability was evaluated with MTT, LDH, and ATPlite assays after 1, 5, and 30 minutes of exposure to each tested formulation. Then, cells were sequentially exposed to formulations and PFD. After 24 hours of exposure to PFD, cell tolerability was evaluated through MTT and ATPlite assays.
Among the formulations tested, LB-VD showed the highest levels of cell viability, cell metabolism, and cell proliferation and induced the lowest release of LDH, whereas the TA-based formulations demonstrated a cytotoxic effect on ARPE-19 cells in vitro. After subsequent 24-hour exposure to PFD, a greater reduction of cell viability was noted for all the formulations; however, this reduction was not significant only for the combination LB-VD-PFD, which was the best tolerated condition.
LB-VD showed a better safety profile compared with all TA-based formulations, even when used in combination with PFD.
In surgical practice, LB-VD may be preferred to TA-based formulations for vitreous staining in the light of its more favorable safety profile.
This PDF is available to Subscribers Only